In the news:
Literature
Aarts PA, van den Broek SA, Prins GW, Kuiken GD, Sixma JJ, Heethaar RM.
Blood platelets are concentrated near the wall and red blood cells, in the center in flowing
blood. Arteriosclerosis 1988 Nov-Dec; 8(6):819-24.
Abdel-Wahab OI, Healy B, Dzik WH.
Effect of
fresh-frozen plasma transfusion on prothrombin time and bleeding in
patients with mild coagulation abnormalities. Transfusion. 2006
Aug;46(8):1279-85.
Aucar JA, Isaak E, Anthony D.
The effect of
red blood cell age on coagulation. Am J Surg. 2009
Dec;198(6):900-4.
Beckmann
SR, Carlile D, Bissinger RC, Burrell M, Winkler T, Shely WW.
Improved coagulation and blood conservation in the golden hours after
cardiopulmonary bypass. J Extra Corpor Technol 2007 Jun;39(2):103-8.
Belcher P R, Muriithi, EW.
Postoperative
bleeding after coronary artery bypass surgery with cardiopulmonary
bypass (letter). Anesth Analg 2002 Nov; 95(5):1466.
Bhardwaj
M, Bunsell R.
Beriplex P/N: an alternative to fresh frozen plasma in severe
haemorrhage. Anaesthesia 2007 Aug;62(8):832-4.
Blome M, Isgro F, Kiessling AH, Skuras J,
Haubelt H, Hellstern P, et al.
Relationship between factor XIII
activity, fibrinogen, haemostasis screening tests and postoperative
bleeding in cardiopulmonary bypass surgery. Thromb Haemost 2005
Jun; 93(6):1101-7.
Blonski
W, Siropaides T, Reddy KR.
Coagulopathy in liver disease. Curr Treat Options Gastroenterol 2007
Dec;10(6):464-73.
Bruce
D, Nokes TJ.
Prothrombin complex concentrate (Beriplex P/N) in severe bleeding:
experience in a large tertiary hospital. Crit Care 2008 Aug
15;12(4):R105. [Epub ahead of print]
Brugts JJ, Mercado N, Hu S, Guarneri M, Price M, Schatz R, et al.
Relation of periprocedural bleeding complications and long-term
outcome in patients undergoing percutaneous coronary
revascularization (from the Evaluation of Oral Xemilofiban in
Controlling Thrombotic Events [EXCITE] Trial). Am J Cardiol 2009
Apr 1;103(7):917-22. Epub 2009 Feb 7.
De Lorenzo C, Calatzis A, Welsch U, Heindl B.
Fibrinogen concentrate reverses dilutional coagulopathy induced in
vitro by saline but not by hydroxyethyl starch 6%. Anesth Analg 2006
Apr;102(4):1194-200.
Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox
KA, Yusuf S.
Adverse impact of bleeding on prognosis in patients
with acute coronary syndromes. Circulation. 2006 Aug
22;114(8):774-82. Epub 2006 Aug 14.
Fenger-Eriksen C, Anker-Moller E, Heslop J, Ingerslev J, Sorensen B.
Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen
concentrate. Br J Anaesth. 2004 Dec 17.
Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sørensen
B. Fibrinogen
concentrate substitution therapy in patients with massive haemorrhage and
low plasma fibrinogen concentrations. Br J Anaesth. 2008
Dec;101(6):769-73.
Fergusson DA, Hébert PC, Mazer CD, Fremes S, Macadams C, Murkin JM, Teoh K,
Duke PC, Arellano R, Blajchman MA, Bussières JS, Côté D, Karski J, Martineau
R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R; the BART
Investigators.
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
N Engl J Med. 2008 May 14. [Epub ahead of print]
Fries D, Innerhofer P, Reif C,
Streif W, Klingler A, Schobersberger W, et al.
The effect of
fibrinogen substitution on reversal of dilutional coagulopathy: an
in vitro model. Anesth Analg 2006 Feb;102(2):347-51.
Fuchs S, Kornowski R, Teplitsky I, Brosh D, Lev E, Vaknin-Assa H, et
al. Major
bleeding complicating contemporary primary percutaneous coronary
interventions-incidence, predictors, and prognostic implications.
Cardiovasc Revasc Med 2009 Apr-Jun;10(2):88-93.
Ganter
MT, Schmuck S, Hamiel CR, Wischmeyer PE, Heule D, Zollinger A, Hofer CK.
Monitoring recombinant
factor VIIa treatment: efficacy depends on high levels of fibrinogen in a
model of severe dilutional coagulopathy. J Cardiothorac Vasc Anesth 2008
Oct;22(5):675-80.
Godje O, Gallmeier U, Schelian M,
Grunewald M, Mair H.
Coagulation factor XIII reduces postoperative
bleeding after coronary surgery with extracorporeal circulation.
Thorac Cardiovasc Surg 2006 Feb;54(1):26-33.
Green
D.
Management of bleeding complications of hematologic malignancies. Semin
Thromb Hemost 2007 Jun;33(4):427-34.
Guo XY, Duan H, Wang JJ, Luo AL, Ye TH, Huang
YG, et al.
Effect
of intraoperative using cell saver on blood sparing and its impact
on coagulation function. Zhongguo Yi Xue Ke Xue Yuan Xue Bao
2004 Apr;26(2):188-91.
Hartmann M, Sucker C, Boehm O, Koch A, Loer S, Zacharowski K.
Effects of
cardiac surgery on hemostasis. Transfus Med Rev. 2006
Jul;20(3):230-241.
Hedner U.
Mechanism of action of Factor VIIa in the treatment of
coagulopathies. Semin Thromb Hemost 2006 Feb;32 Suppl 1:77-85.
Ho
PM. et al.
Incidence of death and acute myocardial infarction associated with stopping
clopidogrel after acute coronary syndrome. JAMA 2008 Feb 6;299(5):532-9.
Holland L, Sarode R.
Should plasma be transfused prophylactically before invasive procedures?
Curr Opin Hematol 2006
Nov;13(6):447-51.
Howes JL, Smith RS, Helmer SD, Taylor SM.
Complications of recombinant
activated human coagulation factor VII. Am J Surg. 2009 Dec;198(6):895-9.
Karkouti
K, Beattie WS, Crowther MA, Callum JL, Chun R, Fremes SE, et al.
The role of recombinant factor VIIa in on-pump cardiac surgery:
Proceedings of the Canadian Consensus Conference. Can J Anaesth.
2007 Jul;54(7):573-82
Kheirabadi
BS, Sieber J, Bukhari T, Rudnicka K, Murcin LA, Tuthill D.
High-pressure fibrin sealant foam: an effective hemostatic agent for
treating severe parenchymal hemorrhage. J Surg Res 2007 Jun 19.
Lecompte T, Hardy JF.
Antiplatelet agents and perioperative
bleeding: [Les inhibiteurs plaquettaires et le saignement
perioperatoire]. Can J Anaesth 2006 Jun;53(6_suppl):S103-S112.
Levi M.
Emergency reversal of antithrombotic treatment. Intern Emerg
Med. 2008 Nov 12.
Levy JH.
Massive transfusion coagulopathy. Semin Hematol 2006 Jan;43(1
Suppl 1):S59-63.
Levi
M, Jonge E.
Clinical relevance of the effects of plasma expanders on coagulation.
Semin Thromb Hemost. 2007 Nov;33(8):810-5.
Li T, Fang Y, Zhu Y, Fan X, Liao Z, Chen F, et al.
A Small Dose of Arginine Vasopressin in Combination with Norepinephrine is a Good Early Treatment for Uncontrolled Hemorrhagic Shock After Hemostasis. J Surg Res. 2010 Mar 4.[Epub ahead of print]
Mitsiakos G, Papaioannou G, Giougi E, Karagianni P, Garipidou V, Nikolaidis
N.
Is the use of rFVIIa safe and effective in bleeding neonates? A
retrospective series of 8 cases. J Pediatr Hematol Oncol 2007
Monroe
DM. Modeling the
action of factor VIIa in dilutional coagulopathy. Thromb Res 2008;122
Suppl 1:S7-S10.
Ozier Y, Schlumberger S.
Pharmacological approaches to reducing
blood loss and transfusions in the surgical patient: [Approches
pharmacologiques de reduction des pertes sanguines et des
transfusions en chirurgie]. Can J Anaesth 2006 Jun;53(6 Suppl):S21-9.
Poullis
M, Manning R, Haskard D, Taylor K.
Reopro removal during cardiopulmonary bypass using a hemoconcentrator. J
Thorac Cardiovasc Surg. 1999 May;117(5):1032-4.
Premaratne S, Razzuk AM,
Premaratne DR, Mugiishi MM, Hasaniya NW, Behling
AF.
Effects
of platelet transfusion on post cardiopulmonary bypass bleeding.
Jpn Heart J 2001 Jul; 42(4):425-33. [Medline
abstract]
Ramnarine IR, Higgins MJ, McGarrity A, Mahmood Z,
Wheatley DJ, Belcher PR.
Autologous blood transfusion for
cardiopulmonary bypass: effects of storage conditions on platelet
function. J Cardiothorac Vasc Anesth 2006 Aug;20(4):541-7.
Reinhart WH, Zehnder L, Schulzki T.
Stored
erythrocytes have less capacity than normal erythrocytes to support
primary haemostasis. Thromb Haemost 2009 Apr;101(4):720-3.
Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, et al. Management of bleeding following major trauma: an updated European guideline. Crit Care. 2010 Apr 6;14(2):R52
Schneeweiss
S, Seeger JD, Landon J, Walker AM.
Aprotinin during coronary-artery bypass grafting and risk of death. N
Engl J Med 2008 Feb 21;358(8):771-83.
Sharma V, Talwar S, Choudhary SK, Lakshmy R, Kale S, Kumar
AS.
Evaluation of
epsilon amino-caproic acid (EACA) and autologous blood as
blood conservation strategies in patients undergoing cardiac surgery. Heart
Lung Circ. 2006 May 11; [Epub ahead of print]
Shaw
AD, Stafford-Smith M, White WD, Phillips-Bute B, Swaminathan M, Milano C, et
al.
The effect of aprotinin on outcome after coronary-artery bypass grafting.
N Engl J Med 2008 Feb 21;358(8):784-93.
Spalding
GJ, Hartrumpf M, Sierig T, Oesberg N, Kirschke CG, Albes JM.
Cost reduction of perioperative coagulation management in cardiac surgery:
value of 'bedside' thrombelastography (ROTEM). Eur J Cardiothorac Surg
2007 Mar 28.
Sniecinski
R, Szlam F, Chen EP, Bader SO, Levy JH, Tanaka KA.
Antithrombin deficiency increases thrombin activity after prolonged
cardiopulmonary bypass. Anesth Analg 2008 Mar;106(3):713-8.
Stanworth
SJ, Hyde CJ, Murphy MF.
Evidence for indications of fresh frozen plasma. Transfus Clin
Biol 2008 Apr 18 [Epub ahead of print]
Tanaka
KA, Taketomi T, Szlam F, Calatzis A, Levy JH.
Improved clot formation by combined administration of activated factor VII
(NovoSeven) and fibrinogen (Haemocomplettan P). Anesth Analg 2008
Mar;106(3):732-8.
Taneja R, Fernandes P, Marwaha G, Cheng D, Bainbridge D.
Perioperative coagulation management and blood conservation in
cardiac surgery: a Canadian Survey. J Cardiothorac Vasc Anesth 2008
Oct;22(5):662-9.
Ucar HI, et al.
Preoperative fibrinogen levels as a predictor of postoperative bleeding
after open heart surgery. The Heart Surgery Forum 2007 Oct;10,(5):E392 -
E396.
Van der Linden P, Ickx BE.
The effects of colloid solutions on hemostasis.
Can J Anaesth 2006 Jun;53(6 Suppl):S30-9.
Verghese
SG. Elective fresh
frozen plasma in the critically ill: what is the evidence? Crit Care
Resusc. 2008 Sep;10(3):264-8.
Weinkove R, Rangarajan S.
Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfus
Med 2008 Jun; 18(3):151-7.
